Wang MM - Search Results

1

Cyclometalated iridium(III) complexes as anti-breast cancer and anti-metastasis agents via STAT3 inhibition.

Su Y, Yang J, Wang MM, Fang HB, Liu HK, Yu ZH, Su Z. Su Y, et al. Among authors: wang mm. J Inorg Biochem. 2024 Feb;251:112427. doi: 10.1016/j.jinorgbio.2023.112427. Epub 2023 Nov 14. J Inorg Biochem. 2024. PMID: 37979498

2

A lysosome-targeted ruthenium(II) polypyridyl complex as photodynamic anticancer agent.

Chen J, Tao Q, Wu J, Wang M, Su Z, Qian Y, Yu T, Wang Y, Xue X, Liu HK. Chen J, et al. J Inorg Biochem. 2020 Sep;210:111132. doi: 10.1016/j.jinorgbio.2020.111132. Epub 2020 Jun 10. J Inorg Biochem. 2020. PMID: 32569884

3

Hydrogen sulfide triggered molecular agent for imaging and cancer therapy.

Ge C, Di X, Han S, Wang M, Qian X, Su Z, Liu HK, Qian Y. Ge C, et al. Chem Commun (Camb). 2021 Feb 23;57(15):1931-1934. doi: 10.1039/d0cc07982k. Chem Commun (Camb). 2021. PMID: 33496706

4

Mitochondria-targeted Pt(IV) prodrugs conjugated with an aggregation-induced emission luminogen against breast cancer cells by dual modulation of apoptosis and autophagy inhibition.

Su Y, Tu Y, Lin H, Wang MM, Zhang GD, Yang J, Liu HK, Su Z. Su Y, et al. Among authors: wang mm. J Inorg Biochem. 2022 Jan;226:111653. doi: 10.1016/j.jinorgbio.2021.111653. Epub 2021 Oct 27. J Inorg Biochem. 2022. PMID: 34740039

5

Fighting metallodrug resistance through alteration of drug metabolism and blockage of autophagic flux by mitochondria-targeting AIEgens.

Su Y, Lin H, Tu Y, Wang MM, Zhang GD, Yang J, Liu HK, Su Z. Su Y, et al. Among authors: wang mm. Chem Sci. 2022 Jan 18;13(5):1428-1439. doi: 10.1039/d1sc06722b. eCollection 2022 Feb 2. Chem Sci. 2022. PMID: 35222927 Free PMC article.

6

A New Strategy to Fight Metallodrug Resistance: Mitochondria-Relevant Treatment through Mitophagy to Inhibit Metabolic Adaptations of Cancer Cells.

Wang MM, Xu FJ, Su Y, Geng Y, Qian XT, Xue XL, Kong YQ, Yu ZH, Liu HK, Su Z. Wang MM, et al. Angew Chem Int Ed Engl. 2022 Jul 4;61(27):e202203843. doi: 10.1002/anie.202203843. Epub 2022 May 5. Angew Chem Int Ed Engl. 2022. PMID: 35384194

7

Unveiling the anti-cancer mechanism for half-sandwich and cyclometalated Ir(iii)-based complexes with functionalized α-lipoic acid.

Wang MM, Xue XL, Sheng XX, Su Y, Kong YQ, Qian Y, Bao JC, Su Z, Liu HK. Wang MM, et al. RSC Adv. 2020 Feb 3;10(9):5392-5398. doi: 10.1039/c9ra10357k. eCollection 2020 Jan 29. RSC Adv. 2020. PMID: 35498295 Free PMC article.

8

Performance of Ir(III)-Based Anticancer Agents in the Treatment of Cisplatin-Resistant Cancer Cells.

Wang MM, Li HM, Deng DP, Su Y, Su Z. Wang MM, et al. ChemMedChem. 2022 Aug 17;17(16):e202200273. doi: 10.1002/cmdc.202200273. Epub 2022 Jul 8. ChemMedChem. 2022. PMID: 35726053

9

The cyclometalated iridium (III) complex based on 9-Anthracenecarboxylic acid as a lysosomal-targeted anticancer agent.

Liu L, Chen J, Wang MM, Huang Y, Qian Y, Xue X, Su Z, Liu HK. Liu L, et al. Among authors: wang mm. J Inorg Biochem. 2022 Oct;235:111913. doi: 10.1016/j.jinorgbio.2022.111913. Epub 2022 Jul 6. J Inorg Biochem. 2022. PMID: 35905643

10

Switching the Mode of Cell Death between Apoptosis and Autophagy by Histone Deacetylase 6 Inhibition Levels.

Zhou AM, Wang MM, Su Y, Yu ZH, Liu HK, Su Z. Zhou AM, et al. Among authors: wang mm. ChemMedChem. 2023 Mar 1;18(5):e202200614. doi: 10.1002/cmdc.202200614. Epub 2023 Jan 18. ChemMedChem. 2023. PMID: 36578101

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

752 results

Search Page

Filters